. 2013 Dec 28;140(3):361–369. doi: 10.1007/s00432-013-1569-z

Table 1.

Median concentration of proangiogenic factors within the three analyzed groups

	Ovarian cancer (n = 58)	Benign ovarian tumors (n = 35)	Normal ovaries (n = 21)	P value
VEGF Median pg/mg protein (range, min–max)	444.64 (0–3,000.00)	2.02 (0–634.75)	4.93 (1.67–79.35)	<0.0001
EMMPRIN Median ng/mg protein (range, min–max)	33.41 (8.48–106.50)	22.94 (13.26–48.38)	21.06 (10.65–40.75)	0.0002
bFGF Median ng/mg protein (range, min–max)	0.97 (0.17–13.32)	2.20 (0.67–50.31)	8.04 (2.56-12.91)	<0.0001

Ovarian cancer (n = 58)

Benign ovarian tumors (n = 35)

Normal ovaries (n = 21)

P value

VEGF

Median pg/mg protein (range, min–max)

444.64 (0–3,000.00)

2.02 (0–634.75)

4.93 (1.67–79.35)

<0.0001

EMMPRIN

Median ng/mg protein (range, min–max)

33.41 (8.48–106.50)

22.94 (13.26–48.38)

21.06 (10.65–40.75)

0.0002

bFGF

Median ng/mg protein (range, min–max)

0.97 (0.17–13.32)

2.20 (0.67–50.31)

8.04 (2.56-12.91)

<0.0001

Bold values are statistically significant (P < 0.05)